Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction.
Ontology highlight
ABSTRACT: Mounting clinical and preclinical evidence supports a key role for sustained adrenergic signaling in the tumor microenvironment as a driver of tumor growth and progression. However, the mechanisms by which adrenergic neurotransmitters are delivered to the tumor microenvironment are not well understood. Here we present evidence for a feed-forward loop whereby adrenergic signaling leads to increased tumoral innervation. In response to catecholamines, tumor cells produced brain-derived neurotrophic factor (BDNF) in an ADRB3/cAMP/Epac/JNK-dependent manner. Elevated BDNF levels in the tumor microenvironment increased innervation by signaling through host neurotrophic receptor tyrosine kinase 2 receptors. In patients with cancer, high tumor nerve counts were significantly associated with increas
SUBMITTER: Allen JK
PROVIDER: S-EPMC6004256 | biostudies-literature | 2018 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA